The Analysis between the Diagnose of Preeclampsia and Eclampsia to Treatment at Dr. H. Jusuf SK Hospital Indonesia

Shafira Aisyah  Azizah; Sari Wijayanti; Syuhada Syuhada; Doris Noviani

doi:10.35916/thmr.v5i1.86

Authors

Shafira Aisyah Azizah Pharmacy Science Study Program, Kaltara Polytechnic, Tarakan City, Indonesia.
Sari Wijayanti Pharmacy Science Study Program, Kaltara Polytechnic, Tarakan City, Indonesia.
Syuhada Syuhada Pharmacy Science Study Program, Kaltara Polytechnic, Tarakan City, Indonesia.
Doris Noviani Department of Midwifery, Faculty of Health Sciences, Borneo Tarakan University, Indonesia.

DOI:

https://doi.org/10.35916/thmr.v5i1.86

Abstract

Preeclampsia and eclampsia are types of gestational hypertension that are considered causes of maternal and perinatal death. Preeclampsia in severe conditions will result in eclampsia accompanied by symptoms of seizures or decreased consciousness. In the condition of preeclampsia, antihypertensive therapy is needed. The use of antihypertensives in patients with Preeclampsia and Eclampsia, namely methyldopa and labetalol, is the first line, and hydralazine, nifedipine, prazosin, and clonidine are the second line. The design of this study is a descriptive cross-sectional study to see the relationship between diagnoses and types of treatment. This research was conducted at Dr.H.Jusuf SK Hospital, Tarakan City, North Kalimantan Province, with secondary data from medical records as research data. The research subjects were pregnant women diagnosed with preeclampsia and eclampsia without accompanying comorbid diseases, with a sample of 49 respondents using a total sampling system. The results of this study found that one patient was diagnosed with Mild Preeclampsia with a single therapy, 45 patients were diagnosed with Severe Preeclampsia with a single therapy, a combination of 2 drugs and a combination of 3 drugs, and three patients were diagnosed with eclampsia with single therapy and a combination of 4 drugs. The data from this study showed a relationship between diagnosis and the type of treatment therapy with a significant value of 0.004 (p<0.05). The findings of this study can be used as a guide for medical therapy by healthcare professionals.

References

Nuraini B. Risk Factors Of Hypertension. J Majority. 2015; 4(5): 10.

Situmorang T, Damantalm Y, Januarista A, Sukri. Factors Associated with the Incidence of Preeclampsia in Pregnant Women at the Kia Polyclinic RSU Anutapura Palu. Tadulako Health Journal. 2(1): 61–75.

Cunningham F, Leveno K, Bloom S, Hauth J, Rouse D, Spong C. Obstetri Williams. 23rd Ed. Jakarta: Egc; 2014.

Martini S, Dewi Rk. The relationship between pregnant women and severe preeclampsia (Peb) to the incidence of low birth weight (LBW). Coping. 2020 Dec 29; 8(4): 455.

Saraswati N, Mardiana M. Risk Factors Associated with the Incidence of Preeclampsia in Pregnant Women (Case Study at Brebes District Hospital in 2014). Unnes Journal Of Public Health. 5(2): 2016.

Yang Y, Le Ray I, Zhu J, Zhang J, Hua J, Reilly M. Preeclampsia Prevalence, Risk Factors, And Pregnancy Outcomes In Sweden And China. Jama Netw Open. 2021 May 10; 4(5): E218401.

Meazaw Mw, Chojenta C, Muluneh Md, Loxton D. Systematic And Meta-Analysis Of Factors Associated With Preeclampsia And Eclampsia In Sub-Saharan Africa. Spradley Ft, Editor. Plos One. 2020; 15(8): 1–23.

Queensland Clinical Guideline (Qcg). Maternity And Neonatal Clinical Guideline Hypertension Disorders Of Pregnancy. Queensland: Queensland Clinical Guideline Steering Committee; 2015 [cited 2023 Feb 25]. Available from: https://www.health.qld.gov.au/qcg/publications

British National Formulary. Bnf 68. London: Bmj Group; 2015.

Maisarah Rh, Sentat T, Warnida H. Evaluation of the Use of Antihypertensive Drugs in Pregnant Women Patients with Preeclampsia at Abdul Wahab Sjahrani Hospital Samarinda. In: Prosiding Seminar Nasional Kesehatan Universitas Tinggi Ilmu Kesehatan Samarida. 2020. p.19-28

Nurizawati, Nurmainah, Purwanti Nu. Profile of Antihypertensive Use in Pre-Eclampsia Patients at Yarsi Pontianak General Hospital in 2018. Journal of Pharmacy Student, Faculty of Medicine, Untan. 2019; 4(1).

Sitorus MF, Amalia L. Relationship between Antihypertensive Use in Preeclampsia Patients and the Incidence of Neonatal Asphyxia and Low Birth Weight in Dr. Hasan Sadikin Bandung. Indones J Clin Pharm. 2020; 9(4): 280.

Miasih K. Pattern of Antihypertensive Prescribing in Preeclampsia Patients at Inpatient Installation at Rsud Wates Kulon Progo Period July-October 2014. Akfarindo. 1(1): 47–53.

Grze G, Walukiewicz M, Rogowicz D, Gilewski W. The Importance And Safety Of Calcium Antagonists In The Treatment Of Hypertens On In Pregnant Women. 2019; 85–8.

Andriana Dd, Utami Ed, Sholihat Nk. Evaluation of the Use of Antihypertensive Drugs in Preeclampsia Patients Hospitalized at Prof. Hospital. Dr. Margono Soekarjo Purwokerto. Acta Pharm Indo. 2018 Mar 31; 6(1): 29.